Cargando…

Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?

In the last 5 years, guidelines have been developed for performing cost-effectiveness analyses (CEAs) for the economic evaluation of vaccination programs against infectious diseases. However, these cost-effectiveness guidelines do not provide specific guidance for including the value of reducing the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mauskopf, Josephine, Masaquel, Catherine, Huang, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. 2021
Materias:	Themed Section: Vaccines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550269/ https://www.ncbi.nlm.nih.gov/pubmed/33431158 http://dx.doi.org/10.1016/j.jval.2020.06.018

Ejemplares similares

What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries
por: Portnoy, Allison, et al.
Publicado: (2021)

How to Prevent Vaccines Falling Victim to Their Own Success: Intertemporal Dependency of Incidence Levels on Indirect Effects in Economic Reevaluations
por: Sandmann, Frank, et al.
Publicado: (2021)

Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030
por: Sim, So Yoon, et al.
Publicado: (2021)

Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018
por: Jit, Mark
Publicado: (2021)

“We Should Be at the Back of the Line”: A Frame Analysis of Old Age Within the Distribution Order of the COVID-19 Vaccine
por: Allen, Laura D, et al.
Publicado: (2021)

Interactions between malaria and human immunodeficiency virus anno 2014
por: Van geertruyden, J-P
Publicado: (2014)

Endophthalmitis
por: Durand, M L
Publicado: (2013)

Skirts as Flags: Transitional Justice, Gender and Everyday Nationalism in Kosovo
por: Krasniqi, Vjollca, et al.
Publicado: (2020)

Modelling in infectious diseases: between haphazard and hazard
por: Neuberger, A., et al.
Publicado: (2013)

Web‐based participatory surveillance of infectious diseases: the Influenzanet participatory surveillance experience
por: Paolotti, D., et al.
Publicado: (2013)

The microarray technology: facts and controversies
por: Lévêque, N., et al.
Publicado: (2012)

Biological warfare, bioterrorism, and biocrime
por: Jansen, H. J., et al.
Publicado: (2014)

Applying proteomic technology to clinical virology
por: Mancone, C., et al.
Publicado: (2012)

The global burden of bacterial and viral zoonotic infections
por: Christou, L.
Publicado: (2011)

How can we better support the public health emergency response workforce during crises?
por: Parry, Amy Elizabeth, et al.
Publicado: (2021)

Prescribing medicines to older people—How to consider the impact of ageing on human organ and body functions
por: Drenth‐van Maanen, A. Clara, et al.
Publicado: (2019)

Les vaccins dans la prévention des infections associées aux soins
por: Gagneux-Brunon, A., et al.
Publicado: (2017)

COVID-19 vaccination and changes in preventive behaviours: findings from the 2021 vaccine roll-out in Switzerland
por: Hitchman, Sara C, et al.
Publicado: (2023)

Measles outbreak in Romania: understanding factors related to suboptimal vaccination uptake
por: Habersaat, Katrine Bach, et al.
Publicado: (2020)

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics
por: Heitz, Frederic, et al.
Publicado: (2009)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Modulation of vaccine response by concomitant probiotic administration
por: Maidens, Catherine, et al.
Publicado: (2013)

Vaccine Development: How Scientific Collaboration and Communication Help Prevent the Spread of Disease: An Interview with Erol Fikrig, MD
por: Turchick, Audrey, et al.
Publicado: (2014)

Evaluation of catastrophic health expenditure risk due to measles in Nigeria
por: Sato, Ryoko
Publicado: (2022)

Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?
por: Petersen, Karin Dam, et al.
Publicado: (2011)

Implications of Differential Age Distribution of Disease-Associated Meningococcal Lineages for Vaccine Development
por: Brehony, Carina, et al.
Publicado: (2014)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
por: Harris, Stephanie A., et al.
Publicado: (2014)

Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression
por: Patel, M., et al.
Publicado: (2015)

Characterization of T-Cell Responses to Conserved Regions of the HIV-1 Proteome in BALB/c Mice
por: Ondondo, Beatrice, et al.
Publicado: (2014)

Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis
por: Rossi, Omar, et al.
Publicado: (2016)

Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
por: Dunning, Andrew J., et al.
Publicado: (2016)

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice
por: Wegmann, Frank, et al.
Publicado: (2015)

Auto-Assembling Detoxified Staphylococcus aureus Alpha-Hemolysin Mimicking the Wild-Type Cytolytic Toxin
por: Fiaschi, Luigi, et al.
Publicado: (2016)

Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap
por: Gray, Glenda E., et al.
Publicado: (2016)

Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein
por: Cimica, Velasco, et al.
Publicado: (2016)

Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms
por: McCraw, Dustin M., et al.
Publicado: (2016)

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
por: Maxfield, Lori F., et al.
Publicado: (2015)

Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
por: Loxton, André G., et al.
Publicado: (2017)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
por: Karasavvas, Nicos, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ltqv6q9vta5cioetbvg7ma98dd